2025

GREENWICH, Conn.–(BUSINESS WIRE)–Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the sale of SSI Strategy (“SSI”), a trusted strategic consulting partner to biotech innovators, to Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle. Financial terms of the transaction were...

A Decade of Impact: - Growth and Scale: From our inception, we've grown to manage over $3.1 billion in assets, with a portfolio encompassing 14 platform investments and more than 35 add-on acquisitions. - Healthcare Reach: In 2024 alone, our portfolio companies enabled over 1 million patient visits, reaching more than 350,000 first-time patients, and employing over 6,000 full-time staff across various healthcare sectors. - ESG Commitment: We've achieved 100% ESG footprint mapping across our portfolio companies, reflecting our dedication to our sustainability program.